Form 4: UiPath Legal Officer Sells Shares Under 10b5-1 Plan

UiPath's GC & Chief Legal Officer, Brad Brubaker, sold 66,665 shares of Class A Common Stock for approximately $15.00 per share under a pre-arranged 10b5-1 plan.

Summary

• Brad Brubaker, UiPath, Inc.'s General Counsel & Chief Legal Officer, reported a sale of Class A Common Stock.
• The transaction involved the disposition of 66,665 shares.
• The shares were sold at a price of $15.0001 per share, with the price range for transactions being $15.0000 to $15.0050.
• The sale was executed on October 6, 2025.
• This transaction was conducted in compliance with a qualified selling plan adopted by Mr. Brubaker pursuant to Rule 10b5-1.
• Following this reported transaction, Mr. Brubaker beneficially owns 690,519 shares of Class A Common Stock directly.

Sentiment

Score: 5

Explanation: The filing reports a routine insider stock sale executed under a pre-arranged 10b5-1 plan. Such transactions are generally considered neutral as they are often for personal financial management and not indicative of a change in the company's fundamental prospects or management's confidence.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This is an individual insider transaction and does not directly relate to broader industry trends or competitive dynamics. Insider sales under 10b5-1 plans are common and typically reflect personal financial planning rather than a change in company fundamentals or industry outlook.

Stakeholder Impact

• Shareholders: A routine insider sale under a 10b5-1 plan typically has minimal direct impact on shareholders, as it is a pre-scheduled event and not a discretionary sale based on new information.

Key Dates

Recommendation

The reported transaction is a routine insider sale by a corporate officer under a Rule 10b5-1 trading plan. These plans are pre-scheduled and designed to allow insiders to sell shares without being accused of trading on material non-public information. As such, this specific filing does not provide new material information about UiPath's operational performance, strategic direction, or financial health that would warrant a change in investment recommendation. Investors should continue to evaluate the company based on its financial reports, market position, and future growth prospects.

Keywords

UiPath, PATH, Insider Trading, Form 4, Stock Sale, Brad Brubaker, 10b5-1 Plan, Legal Officer